DPP10-AS3

Across TCGA pan-cancer cohorts, DPP10-AS3 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated DPP10-AS3 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher DPP10-AS3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DPP10-AS3 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

BLCA, UCEC, and KIRC are the cancer types where DPP10-AS3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
UCEC	OS	Tertile	All	0.777	0.932	<.001	36	view →
KIRC	DFS	Tertile	All	0.208	0.631	.008	30	view →
PAAD	OS	Tertile	All	0.197	0.613	.016	27	view →
PRAD	OS	Tertile	All	0.933	0.995	<.001	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
LGG	OS	Tertile	All	1.000	0.892	.034	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

DPP10-AS3–BLCA (DFS)

Open the BLCA breakdown →